Tissue Engineering Strategies encompass a variety of innovative approaches aimed at creating functional biological substitutes to restore, repair, or replace damaged or diseased tissues. These strategies typically involve the convergence of cells, biomaterials, and signaling molecules to create three-dimensional constructs that mimic the native tissue architecture. One common approach is the use of scaffolds, which provide structural support for cell attachment, proliferation, and differentiation. These scaffolds can be made from natural or synthetic materials, offering a framework for tissue regeneration. Another key strategy involves the use of cells, such as stem cells or differentiated cells, to populate the scaffold and drive tissue formation. Advances in stem cell research have significantly contributed to the development of more robust tissue engineering solutions. Additionally, the incorporation of growth factors, cytokines, and other bioactive molecules into the engineered constructs helps orchestrate cellular behavior and enhance tissue regeneration. Bioprinting technologies have emerged as a cutting-edge strategy, allowing precise layer-by-layer deposition of cells and biomaterials to create complex tissue structures. Tissue engineering strategies are applied across various medical fields, including orthopedics, cardiology, dermatology, and neurology. Continuous research efforts focus on refining these strategies to improve clinical outcomes, enhance biocompatibility, and address specific challenges associated with different tissues and organs. The evolution of tissue engineering continues to play a pivotal role in advancing regenerative medicine and personalized therapeutic interventions.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy